Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Outpatient venous thromboembolism: the importance of optimum prophylaxis

Nature Clinical Practice Cardiovascular Medicine volume 5, pages 12–13 (2008)Cite this article

boxed-textSpencer FA et al. (2007) Venous thromboembolism in the outpatient setting. Arch Intern Med 167: 1471–1475

Almost half of outpatient VTE cases can be traced to hospitalization or outpatient surgery; clinicians must, therefore, institute guideline-specified in-hospital prophylaxis, which should be continued after hospital discharge if appropriate

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Hull RD et al. (2007) Late-breaking clinical trial: extended-duration venous thromboembolism (VTE) prophylaxis in acutely ill medical patients with recent reduced mobility: The EXCLAIM study [abstract #O-S-001]. Presented at the XXIst Congress of the International Society on Thrombosis and Hemostasis: 2007 July 6–12, Geneva, Switzerland

  2. Hull RD et al. (2006) Extended-duration thromboprophylaxis in acutely ill medical patients with recent reduced mobility: methodology for the EXCLAIM study. J Thromb Thrombolysis 22: 31–38

    Article  CAS  Google Scholar 

  3. Cohen AT et al. (2007) Late-breaking clinical trial: a large-scale, global observational study of venous thromboembolism risk and prophylaxis in the acute hospital care setting: the ENDORSE study [abstract #O-S-002]. Presented at the XXIst Congress of the International Society on Thrombosis and Haemostasis: 2007 July 6–12, Geneva, Switzerland

  4. Amin A et al. (2007) Thromboprophylaxis rates in US medical centers: success or failure. J Thromb Haemost 5: 1610–1616

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Alexandra King, Associate Editor, Nature Clinical Practice.

Author information

Author notes

  1. Cardiovascular Division, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA sgoldhaber@partners.org

Authors and Affiliations

  1. SZ Goldhaber is Professor of Medicine at Harvard Medical School and a Senior Staff Member of the Cardiovascular Medicine Division and Director of the Venous Thromboembolism Research Group and the Anticoagulation Service at Brigham and Women's Hospital, Boston, MA, USA.,

    Samuel Z Goldhaber

Authors
  1. Samuel Z Goldhaber
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

SZ Goldhaber has acted as a Consultant for Boehringer Ingelheim, Eisai, GlaxoSmithKline, and Sanofi-Aventis. He has received research support from Boehringer Ingelheim, Bristol-Myers Squibb, Eisai, and Sanofi-Aventis.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Goldhaber, S. Outpatient venous thromboembolism: the importance of optimum prophylaxis. Nat Rev Cardiol 5, 12–13 (2008). https://doi.org/10.1038/ncpcardio1036

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpcardio1036

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing